- Tumor microenvironment evaluation to predict anti-PD-1 response of advanced gastric cancer: Results from a multicenter prospective clinical trial.Liao, Wangjun; Shi, Min; Zeng, Dongqiang; Luo, Huiyan; Xiao, Jian; Ye, Feng; Xiong, Hailin; Yuan, Xia; Huang, Yisheng; Li, Yongqiang; Huang, Na; Wu, Jianhua; Li, Shaowei; Zheng, Siting; Wu, Jiani; Sun, Li; Rong, Xiaoxiang; Wang, Chunlin; Guo, Jian; Deng, QiongGenitourinary Cancers Symposium, San Francisco, CA, 2023-01-19 To 2023-01-21.
- Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer (vol 31, pg 760, 2020)Jiang, Y.; Wang, H.; Wu, J.; Chen, C.; Yuan, Q.; Huang, W.; Li, T.; Xi, S.; Hu, Y.; Zhou, Z.; Xu, Y.; Li, G.*; Li, R.*Annals of Oncology, 2021, 32(4): 578-578.
- KEYNOTE-859 study of pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Outcomes in the protocol-specified PD-L1-selected populationsRha, Sun Young; Wyrwicz, Lucjan; Weber, Patricio Eduardo Yanez; Bai, Yuxian; Ryu, Min-Hee; Lee, Jeeyun; Rivera, Fernando; Alves, Gustavo Vasconcelos; Garrido, Marcelo; Shiu, Kai-Keen; Fernandez, Manuel Gonzalez; Li, Jin; Lowery, Maeve Aine; Cil, Timucin; Cruz, Felipe Melo; Qin, Shukui; Yin, Lina; Bordia, Sonal; Bhagia, Pooja; Oh, Do-YounAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.被引 4
会议论文
Intratumoral CD8+t cell as a potential positive predictor for treatment of chemo-immunotherapy in PD-L1 negative advanced gastric cancer patients.
4阅读
